MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF THE DIABETIC RETINOPATHY TREATMENT IN TYPE 2 DIABETES MELLITUS

We developed a prognostic model for assessing the effectiveness of diabetic retinopathy (DR) treatment in type 2 diabetes mellitus (T2DM) based on the determination of endothelial dysfunction markers. For the first time, a model for predicting the effectiveness of DR treatment using markers of endothelial dysfunction was built for the Ukrainian population, which included EMAP-II and eNOS, indicating the key importance of these markers for determining the effectiveness of DR treatment.